PTGIR and cancer: In contrast, a more recent investigation showed that the release of high levels of PGI2 by cancer‐associated fibroblasts (CAFs) inhibits macrophage phagocytosis while promoting the higher expression of metastasis‐associated and pro‐angiogenic genes in cancer cells through engagement of the PGI2 receptor, PTGIR [76].